| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 767.35B | 801.75B | 818.76B | 876.08B | 762.93B |
| Gross Profit | 351.00B | 357.14B | 346.46B | 393.88B | 346.83B |
| EBITDA | 93.71B | 87.49B | 65.16B | 127.27B | 112.68B |
| Net Income | 28.49B | 16.27B | 8.11B | 73.86B | 61.40B |
Balance Sheet | |||||
| Total Assets | 1.52T | 1.36T | 1.35T | 998.16B | 930.63B |
| Cash, Cash Equivalents and Short-Term Investments | 166.54B | 149.02B | 143.09B | 105.28B | 155.48B |
| Total Debt | 241.21B | 184.20B | 172.76B | 45.37B | 60.12B |
| Total Liabilities | 515.70B | 427.36B | 403.74B | 266.93B | 262.66B |
| Stockholders Equity | 835.88B | 771.88B | 786.69B | 728.47B | 665.23B |
Cash Flow | |||||
| Free Cash Flow | 7.81B | 6.79B | -503.00M | 8.44B | 34.07B |
| Operating Cash Flow | 60.92B | 55.78B | 44.88B | 53.46B | 67.43B |
| Investing Cash Flow | -70.07B | -47.89B | -107.10B | -55.53B | -150.16B |
| Financing Cash Flow | 32.36B | -4.61B | 85.99B | -58.76B | -29.60B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥19.00T | 43.91 | 12.80% | 0.78% | 10.40% | 11.67% | |
70 Outperform | ¥18.87T | 79.20 | 8.95% | 1.88% | 5.02% | 2.02% | |
66 Neutral | ¥405.97B | 15.06 | 11.96% | 3.04% | 2.93% | -26.76% | |
64 Neutral | ¥7.30T | 38.22 | ― | 1.41% | 13.61% | 17.01% | |
63 Neutral | ¥1.89T | 19.77 | 8.05% | 1.58% | 9.30% | 67.08% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | ¥1.15T | 43.72 | 2.99% | 2.62% | -4.29% | 75.25% |